BioScrip Stock Analysis, Valuation (NASDAQ:BIOS)

Add to My Stocks
$2.83 $0.06 (2.17%) BIOS stock closing price Jun 20, 2018 (Closing)

Watch the robo advisor video of BioScrip stock analysis on Amigobulls. Our BIOS analysis video highlights revenue and profit trends along with other important metrics such as valuation to find what makes the stock attractive.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

BioScrip Inc Stock Rating 2.4/5

We at Amigobulls use various financial measures including profit margins, revenue growth and dividends for BIOS stock analysis. BioScrip valuation analysis is based on relative valuation multiples like PE ratio and price to sales ratio. BioScrip stock rating encapsulates our opinion about the company based on the fundamentals.

Should you buy BIOS stock?

  • The lower PS ratio 0.5 for BIOS stock versus Medical sector average of 6.5 is a positive for the company.
  • BioScrip generates a high return on invested capital of 0.9.

Should you sell BIOS stock?

  • BioScrip sales shrank by -22.6% year-over-year in 2018-03.
  • Over the last 5 years, the company registered a poor revenue growth of 2.6.
  • BioScrip registered an average TTM Net loss of -9.2%.
  • The lack of profits renders the PE ratio useless for BIOS stock.
  • BioScrip has a negative return on equity of -1597.8. This indicates that the firm is inefficient at generating profits.
  • The company has negative Free Cash Flows (FCF), with a negative FCF margin of -4.6.

Comments on this video and BioScrip stock

Investors can use Amigobulls BioScrip stock analysis as a tool to arrive at accurate conclusions regarding financial health of the company and its valuation. Fundamentals of a company give detailed information which helps in making invesment decisions.

Among the financials of the company, BioScrip revenue growth along with the profit or net income give a clear picture of the financial health. Investors could make use of BIOS technical analysis to check whether the fundamental story is reflected in the market sentiment.